Ruiz-Gómez J, Valdespino JL, Olaiz-Fernández G, Arias-Toledo E, Sepúlveda J

Language: Spanish
References: 18
Page: 370-376
PDF size: 176.88 Kb.

ABSTRACT

Objective. To analyze the frequency and distribution of protective antibodies against measles in a sample of children from 1-9 years old representative of each of the 32 states in Mexico; to contribute to the evaluation of the measles vaccination programs. Material and Methods. Measles antibodies (plaque reduction neutralization (PRN) assay) were studied in 6 270 sera selected from the 24 232 sera from children 1-9 years of age, collected by the 2000 National Health Survey (ENSA 2000) that was conducted from November 1999 to June 2000. Results. Proportion of seropositive samples (›120 IU/L) among 1-4 year-old children (98.3% [95%CI: 97.7-98.8]) was less than that of 5-9 year-old children (99.4% [95%CI: 99.2-99.6]; p›0.001). Seropositivity was associated with the number of measles and/or measles-rubella-mumps vaccine doses and was not associated with gender, place of residence or socio-economic status. Conclusions. The results show that there is adequate vaccination coverage. However, the expansion of data revealed that there are 417 000 children with negative antibody titers who are susceptible to acquiring the disease, transmitting the virus and causing outbreaks.

REFERENCES

1. Fernández-de Castro J. Vacunas anti-sarampión. En: Escobar-Gutiérrez A, Valdespino-Gómez J, Sepúlveda J, eds. Vacunas, ciencia y salud. México: Secretaría de Salud, 1992:143-162.

2. Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned. J Infect Dis 2004;189(Suppl 1):S243-S250.

3. Herrera-Téllez J. Aspectos sociales y operativos de las campañas de vacunación. En: Escobar-Gutiérrez A, Valdespino-Gómez J, Sepúlveda J, eds. Vacunas, ciencia y salud. México: Secretaría de Salud, 1992:143-162.

4. Pan American Health Organization. Measles and rubella surveillance in the Americas. Measles outbreak in Mexico. Measles Weekly Bulletin 2004;10.

5. Gudiño-Rosales J, Ramírez-González J, González-Durán E, Cruz-Ramírez E, Wong-Arámbula C, Bautista-Matías N, et al. Aislamiento y genotipificación de sarampión de los brotes de 2003-2006 en México. En: Secretaría de Salud, ed. XI Encuentro Nacional de Investigadores. Acapulco, Gro, septiembre 27-30. México: Secretaría de Salud, 2006:12.

6. Camacho-Amor ML, Valdespino-Gomez JL, Ayala-Gonzalez M, Diaz-Ortega JL, Gonzalez-Velazquez MS, Morales-Romo A, et al. Evaluation of the cold chain and follow-up of the potency of the antimeasles vaccine in the field. Bol Med Hosp Infant Mex 1990;47(7):506-511.

7. Strebel P, Papania M, Halsey N. Measles caccine. In: Plotkin S, Orenstein W, eds. Vaccines. USA: Elsevier Inc, 2004:389-440.

8. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162(5):1036-1042.

9. Stokes J Jr, Reilly CM, Buynak EB, Hilleman MR. Immunologic studies of measles. Am J Hyg 1961;74:293-303.

10. Albrecht P. Measles plaque reduction neutralization test in 24-well tissue culture trays, standard operating procedure developed and established by the Food and Drug Administration. Food and Drug Administration, 1980.

11. Hutchins SS, Redd SC, Schrag S, Kruszon-Moran D, Wooten K, McQuillan GM, et al. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. Med Gen Med 2001:E5.

12. Sepúlveda J, Tapia-Conyer R, Valdespino JL, Quiroz G, Salvatierra B, Zárate ML, et al. Seroepidemiology of measles in Mexico. Salud Publica Mex 1992;34(2):148-156.

13. Valdespino JL, Olaiz G, Mendoza L, Palma O, Velázquez O, Tapia R, et al. Encuesta Nacional de Salud 2000. Tomo 1. Vivienda, población y utilización de servicios de salud. Cuernavaca, México: Instituto Nacional de Salud Pública; 2003.

14. Delgado JL, Johnson CL, Roy I, Trevino FM. Hispanic Health and Nutrition Examination Survey: methodological considerations. Am J Public Health 1990;80(Suppl):S6-S10.

15. Jaye A, Magnusen AF, Sadiq AD, Corrah T, Whittle HC. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J Clin Invest 1998;102(11):1969-1977.

16. Instituto Nacional de Estadística Geografía e Informática. XI Censo General de Población y Vivienda 1990. México: INEGI, 1990.

17. Gutierrez G, Tapia-Conyer R, Guiscafre H, Reyes H, Martinez H, Kumate J. Impact of oral rehydration and selected public health interventions on reduction of mortality from childhood diarrhoeal diseases in Mexico. Bull World Health Organ 1996;74(2):189-197.

18. Chen RT, Goldbaum GM, Wassilak SG, Markowitz LE, Orenstein WA. An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol 1989;129(1):173-182.